Cutting edge: Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I-molecules

Marco Colonna, Jacqueline Samaridis, Marina Cella, Lena Angman, Rachel L. Allen, Chris A. O'Callaghan, Rod Dunbar, Graham S. Ogg, Vincenzo Cerundolo, Antonius Rolink

Research output: Contribution to journalArticle

423 Scopus citations

Abstract

Leukocyte activation can be negatively regulated by inhibitory receptors specific for MHC class I-molecules. While one inhibitory receptor Hg-like transcript 2 (ILT2), is expressed by all lymphoid and myelomonocytic cell types, other receptors display a more selective tissue distribution. Here we characterize an inhibitory receptor termed ILT4, which is selectively expressed in monocytes, macrophages and dendritic cells (DCs), binds classical class molecules and the nonclassical class I molecules HLA-G, and transduces negative signals that can inhibit early signaling events triggered by stimulatory receptors. ILT4 may control inflammatory responses and cytotoxicity mediated by myelomonocytic cells and may modulate their Ag presenting functions, focusing immune responses to microbial challenges and avoiding autoreactivity.

Original languageEnglish
Pages (from-to)3096-3100
Number of pages5
JournalJournal of Immunology
Volume160
Issue number7
StatePublished - Apr 1 1998
Externally publishedYes

Fingerprint Dive into the research topics of 'Cutting edge: Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I-molecules'. Together they form a unique fingerprint.

  • Cite this

    Colonna, M., Samaridis, J., Cella, M., Angman, L., Allen, R. L., O'Callaghan, C. A., Dunbar, R., Ogg, G. S., Cerundolo, V., & Rolink, A. (1998). Cutting edge: Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I-molecules. Journal of Immunology, 160(7), 3096-3100.